These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9231421)

  • 1. OHIO-1 beta-lactamase mutants: Asp179Gly mutation confers resistance to ceftazidime.
    Bonomo RA; Rudin SD; Shlaes DM
    FEMS Microbiol Lett; 1997 Jul; 152(2):275-8. PubMed ID: 9231421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9.
    Delmas J; Robin F; Carvalho F; Mongaret C; Bonnet R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):731-8. PubMed ID: 16436733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.
    Kurokawa H; Shibata N; Doi Y; Shibayama K; Kamachi K; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2981-3. PubMed ID: 12937007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
    Perilli M; Segatore B; Tavio M; Setacci D; Celenza G; De Santis F; Pellegrini C; Rossolini GM; Amicosante G
    J Chemother; 2007 Apr; 19(2):123-6. PubMed ID: 17434819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of an OHIO-1 beta-lactamase bearing Met69Ile and Gly238Ser mutations.
    Bonomo RA; Knox JR; Rudin SD; Shlaes DM
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1940-3. PubMed ID: 9303389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate.
    Hidri N; Barnaud G; Decré D; Cerceau C; Lalande V; Petit JC; Labia R; Arlet G
    J Antimicrob Chemother; 2005 Apr; 55(4):496-9. PubMed ID: 15722393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
    Mammeri H; Nazic H; Naas T; Poirel L; Léotard S; Nordmann P
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4050-3. PubMed ID: 15388478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.
    Vakulenko S; Golemi D
    Antimicrob Agents Chemother; 2002 Mar; 46(3):646-53. PubMed ID: 11850243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid substitutions at Ambler position Gly238 in the SHV-1 beta-lactamase: exploring sequence requirements for resistance to penicillins and cephalosporins.
    Hujer AM; Hujer KM; Helfand MS; Anderson VE; Bonomo RA
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3971-7. PubMed ID: 12435703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance.
    Hujer AM; Hujer KM; Bonomo RA
    Biochim Biophys Acta; 2001 May; 1547(1):37-50. PubMed ID: 11343789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
    Poirel L; Mammeri H; Nordmann P
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations altering substrate specificity in OHIO-1, and SHV-1 family beta-lactamase.
    Shlaes DM; Currie-McCumber C
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):411-5. PubMed ID: 1599426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OHIO-1 beta-lactamase mutants: the Arg244Ser mutant and resistance to beta-lactams and beta-lactamase inhibitors.
    Lin S; Thomas M; Mark S; Anderson V; Bonomo RA
    Biochim Biophys Acta; 1999 Jun; 1432(1):125-36. PubMed ID: 10366735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
    Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.
    Poirel L; Gniadkowski M; Nordmann P
    J Antimicrob Chemother; 2002 Dec; 50(6):1031-4. PubMed ID: 12461028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.